1 Min Read
Jan 15 (Reuters) - Transoma Medical Inc on Tuesday said it sees its initial public offering of 4 million shares at an estimated price of $14 to $16 per share.
In an amended filing with the U.S Securities and Exchange Commission, the medical products maker said stockholders will sell an additional 217,600 shares.
The St. Paul, Minnesota-based company said it applied for a Nasdaq listing under the symbol "TSMA." (Reporting by Supantha Mukherjee in Bangalore)